Tonix Pharm Holdings (TNXP)

$33.99 -1.68 (-4.71%)
Market Cap 262.43M
Revenue (ttm) 10.09M
Net Income (ttm) -130.04M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,288.80%
Debt to Equity Ratio 0.00
Volume 535,700
Avg Vol 913,952
Day's Range N/A - N/A
Shares Out 7.36M
Stochastic %K 59%
Beta 2.09
Analysts Strong Sell
Price Target $60.00

Company Profile

Tonix Pharmaceuticals Holding Corp., a biopharmaceutical company, focuses on developing and commercializing therapeutics to treat and prevent human disease. It markets Zembrace SymTouch and Tosymra for the treatment of acute migraine with or without aura in adults. Its portfolio focuses on central nervous system disorders, as well as immunology, infectious disease, and rare disease product candidates. The company's products pipeline include TNX-102 SL (cyclobenzaprine HCl sublingual tablet), for...

Industry: Biotechnology
Sector: Healthcare
Phone: 862 799 8599
Fax: 862 904 8163
Address:
26 Main Street, Suite 101, Chatham, United States
Stockeye2
Stockeye2 Jun. 26 at 8:29 AM
$TNXP
0 · Reply
AlwaysABullNeverABear
AlwaysABullNeverABear Jun. 26 at 8:16 AM
$TNXP
0 · Reply
Weedman99
Weedman99 Jun. 26 at 7:47 AM
$TNXP Fibromyalgia sufferers have been waiting 15 years for this drug! Then comes insomnia, muscle injuries, stress, chronic pain of all kinds... Tonix will flood the world with TX102, and billions will be rolling in like hotcakes!
0 · Reply
jbrennz
jbrennz Jun. 26 at 4:03 AM
$TNXP I am invested in this stock. Positive data, patients need help, short fuse to acceptance decision. SP appreciation opportunity!
0 · Reply
Rbnhoodsfinest
Rbnhoodsfinest Jun. 26 at 3:53 AM
$TNXP everyday that goes by i get a little more excited. Im down to 206 shares. It’s definitely enough to put a little smile on my face if all goes well.
1 · Reply
BiotechBonesaw
BiotechBonesaw Jun. 26 at 3:29 AM
$ALT $JFBR $IMRX $NUVB $TNXP Are 5 of my kitties
0 · Reply
IBIO_KEVINTL
IBIO_KEVINTL Jun. 26 at 12:12 AM
$TNXP Russel Friday after close. Let the weekend get the word out. Monday morning 🔥 burn the shorts. 🍀
0 · Reply
Rickerthestockpicker1
Rickerthestockpicker1 Jun. 25 at 11:54 PM
$TNXP I’m in not selling Certainly would be nice to have an early approval and burn the shorts which I believe will happen
0 · Reply
Terminator1
Terminator1 Jun. 25 at 11:53 PM
$TNXP well dip a little tomorrow am so I can buy more then, 💪🔥🚀
0 · Reply
deluna562
deluna562 Jun. 25 at 11:39 PM
$TNXP
0 · Reply
Latest News on TNXP
Tonix Pharmaceuticals: Big Risk, Bigger Reward - Initiating With A Buy

Jun 16, 2025, 11:30 AM EDT - 9 days ago

Tonix Pharmaceuticals: Big Risk, Bigger Reward - Initiating With A Buy

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the Annual European Congress of Rheumatology (EULAR) 2025

Jun 16, 2025, 7:00 AM EDT - 9 days ago

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the Annual European Congress of Rheumatology (EULAR) 2025

Tonix Pharmaceuticals: Is The Recent Sell-Off A Buy Occasion?

Jun 13, 2025, 7:30 AM EDT - 12 days ago

Tonix Pharmaceuticals: Is The Recent Sell-Off A Buy Occasion?

Tonix Pharmaceuticals Announces Appointment of Commercial Industry Veteran, James “Jim” Hunter, to Board of Directors

Jun 13, 2025, 7:00 AM EDT - 12 days ago

Tonix Pharmaceuticals Announces Appointment of Commercial Industry Veteran, James “Jim” Hunter, to Board of Directors

Tonix Pharmaceuticals Announces Presentation at the 2025 BIO International Convention

Jun 10, 2025, 7:00 AM EDT - 15 days ago

Tonix Pharmaceuticals Announces Presentation at the 2025 BIO International Convention

Tonix Pharmaceuticals Announces Poster Presentation at the Annual European Congress of Rheumatology (EULAR) 2025

Jun 5, 2025, 7:00 AM EDT - 20 days ago

Tonix Pharmaceuticals Announces Poster Presentation at the Annual European Congress of Rheumatology (EULAR) 2025

Tonix Pharmaceuticals Announces Presentation at the A.G.P. Annual Healthcare Company Showcase

May 22, 2025, 7:00 AM EDT - 4 weeks ago

Tonix Pharmaceuticals Announces Presentation at the A.G.P. Annual Healthcare Company Showcase

Tonix Pharmaceuticals Announces First Patient Dosed in Phase 2 OASIS Study of TNX-102 SL for Reduction of Acute Stress Reaction

May 21, 2025, 7:00 AM EDT - 5 weeks ago

Tonix Pharmaceuticals Announces First Patient Dosed in Phase 2 OASIS Study of TNX-102 SL for Reduction of Acute Stress Reaction

Tonix Pharmaceuticals Announces Appointment of Joseph Hand, Esq., as General Counsel and Executive Vice President of Operations

May 14, 2025, 7:00 AM EDT - 6 weeks ago

Tonix Pharmaceuticals Announces Appointment of Joseph Hand, Esq., as General Counsel and Executive Vice President of Operations

Tonix Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Highlights

May 12, 2025, 4:30 PM EDT - 6 weeks ago

Tonix Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Highlights

Tonix Pharmaceuticals Presented Preclinical Data on Gastric Cancer Models at the American Association for Cancer Research (AACR) 2025 Annual Meeting

Apr 29, 2025, 9:05 AM EDT - 2 months ago

Tonix Pharmaceuticals Presented Preclinical Data on Gastric Cancer Models at the American Association for Cancer Research (AACR) 2025 Annual Meeting

Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress Washington 2025

Apr 24, 2025, 7:55 AM EDT - 2 months ago

Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress Washington 2025

Tonix Pharmaceuticals Announces Oral Presentation and Panel Participation at the World Vaccine Congress Washington 2025

Apr 16, 2025, 7:00 AM EDT - 2 months ago

Tonix Pharmaceuticals Announces Oral Presentation and Panel Participation at the World Vaccine Congress Washington 2025

Tonix Pharmaceuticals and Makana Therapeutics Announce Collaboration Combining Tonix's Anti-CD40L Monoclonal Antibody (TNX-1500) with Makana's Genetically Engineered Organs in Preclinical and Clinical Xenotransplantation Studies

Apr 9, 2025, 7:00 AM EDT - 2 months ago

Tonix Pharmaceuticals and Makana Therapeutics Announce Collaboration Combining Tonix's Anti-CD40L Monoclonal Antibody (TNX-1500) with Makana's Genetically Engineered Organs in Preclinical and Clinical Xenotransplantation Studies

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting

Apr 7, 2025, 7:00 AM EDT - 2 months ago

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting

Tonix Pharmaceuticals to Present at the 2025 Jones Trading Healthcare and Innovation Conference

Apr 2, 2025, 7:00 AM EDT - 3 months ago

Tonix Pharmaceuticals to Present at the 2025 Jones Trading Healthcare and Innovation Conference

Tonix Pharmaceuticals Launches TONIX ONE™, a Fully-Integrated Digital Platform Designed to Help Patients Better Understand and Manage Their Migraine Condition

Apr 1, 2025, 7:00 AM EDT - 3 months ago

Tonix Pharmaceuticals Launches TONIX ONE™, a Fully-Integrated Digital Platform Designed to Help Patients Better Understand and Manage Their Migraine Condition

Tonix's Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year

Mar 31, 2025, 7:00 AM EDT - 3 months ago

Tonix's Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year

Tonix Pharmaceuticals Announces Presentation at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting

Mar 27, 2025, 7:00 AM EDT - 3 months ago

Tonix Pharmaceuticals Announces Presentation at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting

Tonix Pharmaceuticals: Potential To Have 'First' New Fibromyalgia Drug In 15 Years

Mar 26, 2025, 2:30 AM EDT - 3 months ago

Tonix Pharmaceuticals: Potential To Have 'First' New Fibromyalgia Drug In 15 Years

Top 2 Health Care Stocks That Are Ticking Portfolio Bombs

Mar 25, 2025, 8:16 AM EDT - 3 months ago

Top 2 Health Care Stocks That Are Ticking Portfolio Bombs

ARQT

Tonix Pharmaceuticals Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for TNX-102 SL for the Management of Fibromyalgia

Mar 24, 2025, 8:00 AM EDT - 3 months ago

Tonix Pharmaceuticals Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for TNX-102 SL for the Management of Fibromyalgia

As Mpox Cases Spread Around the World, Tonix Pharmaceuticals' Single-Dose Vaccine TNX-801 Has Potential to Slow the Spread

Mar 20, 2025, 7:00 AM EDT - 3 months ago

As Mpox Cases Spread Around the World, Tonix Pharmaceuticals' Single-Dose Vaccine TNX-801 Has Potential to Slow the Spread

Absci Posts Downbeat Results, Joins HealthEquity, Tonix Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Mar 19, 2025, 8:15 AM EDT - 3 months ago

Absci Posts Downbeat Results, Joins HealthEquity, Tonix Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

ABSI HQY

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

Mar 18, 2025, 4:30 PM EDT - 3 months ago

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring 2025

Mar 13, 2025, 7:00 AM EDT - 3 months ago

Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring 2025

Tonix's TNX-1500 Shows Promise in Preventing Organ Transplant Rejections of Either Human or Pig Organs; Autoimmune Diseases Also a Target

Mar 12, 2025, 7:30 AM EDT - 3 months ago

Tonix's TNX-1500 Shows Promise in Preventing Organ Transplant Rejections of Either Human or Pig Organs; Autoimmune Diseases Also a Target

Tonix Pharmaceuticals to Present at the Zacks SCR Life Sciences Virtual Investor Forum on March 13th

Mar 11, 2025, 7:00 AM EDT - 3 months ago

Tonix Pharmaceuticals to Present at the Zacks SCR Life Sciences Virtual Investor Forum on March 13th

Tonix Pharmaceuticals Announces Grant by Medical CBRN Defense Consortium (MCDC) for Development of TNX-801, the Company's Single-Dose Mpox and Smallpox Vaccine Candidate

Mar 10, 2025, 8:00 AM EDT - 3 months ago

Tonix Pharmaceuticals Announces Grant by Medical CBRN Defense Consortium (MCDC) for Development of TNX-801, the Company's Single-Dose Mpox and Smallpox Vaccine Candidate

Tonix Pharmaceuticals to Present at the 2025 Virtual Investor Summit

Mar 5, 2025, 7:00 AM EST - 4 months ago

Tonix Pharmaceuticals to Present at the 2025 Virtual Investor Summit

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at 7th International Congress on Controversies in Fibromyalgia

Mar 4, 2025, 7:00 AM EST - 4 months ago

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at 7th International Congress on Controversies in Fibromyalgia

Tonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and Year-End Cash

Feb 7, 2025, 8:30 AM EST - 4 months ago

Tonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and Year-End Cash

Tonix Pharmaceuticals Announces Positive Topline Results from Phase 1 Trial for TNX-1500, a Next Generation anti-CD40L mAb Candidate for Prevention of Kidney Transplant Rejection and Treatment of Autoimmune Diseases

Feb 6, 2025, 8:00 AM EST - 4 months ago

Tonix Pharmaceuticals Announces Positive Topline Results from Phase 1 Trial for TNX-1500, a Next Generation anti-CD40L mAb Candidate for Prevention of Kidney Transplant Rejection and Treatment of Autoimmune Diseases

Tonix Pharmaceuticals to Participate in the 2025 BIO CEO & Investor Conference

Feb 5, 2025, 7:00 AM EST - 5 months ago

Tonix Pharmaceuticals to Participate in the 2025 BIO CEO & Investor Conference

Tonix Pharmaceuticals Promotes Siobhan Fogarty to Chief Technical Officer

Feb 4, 2025, 7:00 AM EST - 5 months ago

Tonix Pharmaceuticals Promotes Siobhan Fogarty to Chief Technical Officer

Tonix Pharmaceuticals Announces 1-for-100 Reverse Stock Split

Feb 3, 2025, 8:05 AM EST - 5 months ago

Tonix Pharmaceuticals Announces 1-for-100 Reverse Stock Split

Tonix Pharmaceuticals Announces PDUFA Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for TNX-102 SL for Fibromyalgia

Dec 23, 2024, 8:00 AM EST - 6 months ago

Tonix Pharmaceuticals Announces PDUFA Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for TNX-102 SL for Fibromyalgia

FDA accepts Tonix's NDA for non-opioid fibromyalgia drug TNX-102 SL

Dec 17, 2024, 10:59 AM EST - 6 months ago

FDA accepts Tonix's NDA for non-opioid fibromyalgia drug TNX-102 SL

Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia

Dec 17, 2024, 8:00 AM EST - 6 months ago

Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia

Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights

Dec 16, 2024, 11:40 AM EST - 6 months ago

Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights

Tonix's TNX 102-SL Could Offer New Hope of Pain Relief Without Narcotics for Fibromyalgia Sufferers

Dec 9, 2024, 7:30 AM EST - 7 months ago

Tonix's TNX 102-SL Could Offer New Hope of Pain Relief Without Narcotics for Fibromyalgia Sufferers

Tonix Pharmaceuticals to Participate in the NobleCon20 Investor Conference

Nov 26, 2024, 7:00 AM EST - 7 months ago

Tonix Pharmaceuticals to Participate in the NobleCon20 Investor Conference

Muscarinic Acetylcholine Receptor M1 Antagonists Pipeline Research Report 2024: Comprehensive Insights on 8+ Drugs Featuring Tonix Pharmaceuticals, BMS, WinSanTor, and Apnimed

Nov 21, 2024, 4:27 AM EST - 7 months ago

Muscarinic Acetylcholine Receptor M1 Antagonists Pipeline Research Report 2024: Comprehensive Insights on 8+ Drugs Featuring Tonix Pharmaceuticals, BMS, WinSanTor, and Apnimed

Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual

Nov 18, 2024, 4:05 PM EST - 7 months ago

Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual

Tonix Pharmaceuticals Targets Rapid Migraine Relief With Non-Oral Treatments

Nov 14, 2024, 7:30 AM EST - 7 months ago

Tonix Pharmaceuticals Targets Rapid Migraine Relief With Non-Oral Treatments

Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting

Nov 13, 2024, 4:05 PM EST - 8 months ago

Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting

Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company's Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised Animals

Nov 13, 2024, 9:05 AM EST - 8 months ago

Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company's Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised Animals

Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024

Nov 1, 2024, 7:00 AM EDT - 8 months ago

Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024

Tonix Pharmaceuticals to Present at BIO-Europe® 2024

Oct 29, 2024, 8:00 AM EDT - 8 months ago

Tonix Pharmaceuticals to Present at BIO-Europe® 2024

Tonix Pharmaceuticals to Present at the 2024 ThinkEquity Conference

Oct 25, 2024, 8:00 AM EDT - 8 months ago

Tonix Pharmaceuticals to Present at the 2024 ThinkEquity Conference

Stockeye2
Stockeye2 Jun. 26 at 8:29 AM
$TNXP
0 · Reply
AlwaysABullNeverABear
AlwaysABullNeverABear Jun. 26 at 8:16 AM
$TNXP
0 · Reply
Weedman99
Weedman99 Jun. 26 at 7:47 AM
$TNXP Fibromyalgia sufferers have been waiting 15 years for this drug! Then comes insomnia, muscle injuries, stress, chronic pain of all kinds... Tonix will flood the world with TX102, and billions will be rolling in like hotcakes!
0 · Reply
jbrennz
jbrennz Jun. 26 at 4:03 AM
$TNXP I am invested in this stock. Positive data, patients need help, short fuse to acceptance decision. SP appreciation opportunity!
0 · Reply
Rbnhoodsfinest
Rbnhoodsfinest Jun. 26 at 3:53 AM
$TNXP everyday that goes by i get a little more excited. Im down to 206 shares. It’s definitely enough to put a little smile on my face if all goes well.
1 · Reply
BiotechBonesaw
BiotechBonesaw Jun. 26 at 3:29 AM
$ALT $JFBR $IMRX $NUVB $TNXP Are 5 of my kitties
0 · Reply
IBIO_KEVINTL
IBIO_KEVINTL Jun. 26 at 12:12 AM
$TNXP Russel Friday after close. Let the weekend get the word out. Monday morning 🔥 burn the shorts. 🍀
0 · Reply
Rickerthestockpicker1
Rickerthestockpicker1 Jun. 25 at 11:54 PM
$TNXP I’m in not selling Certainly would be nice to have an early approval and burn the shorts which I believe will happen
0 · Reply
Terminator1
Terminator1 Jun. 25 at 11:53 PM
$TNXP well dip a little tomorrow am so I can buy more then, 💪🔥🚀
0 · Reply
deluna562
deluna562 Jun. 25 at 11:39 PM
$TNXP
0 · Reply
AlwaysABullNeverABear
AlwaysABullNeverABear Jun. 25 at 9:03 PM
$TNXP let’s get through tomorrow then Friday will be the interesting day when it goes live on russle
1 · Reply
shuffle_
shuffle_ Jun. 25 at 8:49 PM
$TNXP what’s with the bearish sentiment? This has great potential
0 · Reply
Stockgirl1010
Stockgirl1010 Jun. 25 at 8:41 PM
$BBAI $NUVB $TNXP $UNCY can someone explain this phenomenon? i’ve noticed this as well
3 · Reply
Steve19834
Steve19834 Jun. 25 at 8:35 PM
$TNXP can anyone explain why stocks go up before hours and then suck all day and then go up after hours as well? $BBAI $NUVB $UNCY all done the same
5 · Reply
Tom678
Tom678 Jun. 25 at 8:06 PM
$TNXP after hour crazy all weak hands got flashed
0 · Reply
willie_p_deuce
willie_p_deuce Jun. 25 at 7:48 PM
$TNXP waiting on Christmas is quicker than waiting on August 15....jeepers wally....WTF....lets go already!
0 · Reply
JackSurvived
JackSurvived Jun. 25 at 7:36 PM
$TNXP
0 · Reply
Nobodylikesbears
Nobodylikesbears Jun. 25 at 7:33 PM
$TNXP Higher bottoms = higher highs incoming
0 · Reply
MarkWeir
MarkWeir Jun. 25 at 6:59 PM
$TNXP 👏🏻👏🏻👏🏻
0 · Reply
Tom678
Tom678 Jun. 25 at 6:45 PM
$TNXP great buying opportunity, buying here. Know what you hold. Can’t shake us diamond hands
0 · Reply
TOOKPROFITS
TOOKPROFITS Jun. 25 at 6:36 PM
$TNXP back to 20s tomorrow
1 · Reply
FerretsOfWallStreet
FerretsOfWallStreet Jun. 25 at 6:29 PM
$TNXP
0 · Reply